All Stories

  1. Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary embolism who require secondary thromboprophylaxis
  2. Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review
  3. Review of Pulmonary Embolism
  4. VTE risk scores in guidelines in nonsurgical hospitalized patients with suspected VTE
  5. Sequential Nadroparin and Rivaroxaban in Treatment of Pulmonary Embolism
  6. Diagnostic Strategy Using an Elevated Age-Adjusted D-Dimer Threshold and Thromboembolic Events
  7. A Pulmonary Embolism Diagnostic Strategy in Patients Hospitalized for COPD Exacerbation
  8. Optimal risk assessment score of venous thromboembolism for patients with lung Cancer
  9. Clinical Implications of LTA 4 H Genetic Polymorphism in Patients with COPD
  10. Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
  11. Depletion of PPARγ SUMOylation exaggerates intermittent hypoxia-induced cognitive ecline
  12. Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD
  13. Current Status of the Treatment of Cancer-associated Venous Thromboembolism
  14. An algorithm most appropriate for the prediction of pulmonary embolism in AECOPD
  15. The association between pulmonary embolism and genomic alterations in NSCLC
  16. The role of a biomarker panel in BALF in patients with pulmonary nodules less than 8 mm
  17. Diagnosis of Pulmonary Embolism with d-Dimer Testing
  18. Update on Clinical Aspects of COPD
  19. Coagulation factor IV is an indicator of PE in patients with primary lung cancer
  20. Comparison among different presentations of venous thromboembolism because of lung cancer
  21. A modified risk assessment approach for PAH
  22. The influence of anemia on one-year exacerbation rate of patients with COPD-PH
  23. The influence of compliance to LTOT in the development of PH in patients with COPD with hypoxemia
  24. The relationship between tumor markers and pulmonary embolism in lung cancer
  25. Can we predict the prognosis of COPD with a routine blood test?
  26. A 12 -month follow-up study on the preventive effect of lansuoprazole on AECOPD